| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1702 |
| Trial ID | NCT03076437 |
| Disease | Chronic Lymphocytic Leukemia | Acute Lymphoblastic Leukemia | Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Completed |
| Title | Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies |
| Year | 2016 |
| Country | China |
| Company sponsor | Shenzhen Institute for Innovation and Translational Medicine |
| Other ID(s) | SIITM20160115 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||||
|
|||||||||||